A critical moment: Standardizing red blood cell antibody reporting to reduce hemolytic disease of the fetus and newborn risk

Authors

• Molly Sherwood, Allo Hope Foundation, Tuscaloosa, Alabama, USA.
• Bethany Weathersby, Allo Hope Foundation, Tuscaloosa, Alabama, USA.
• Kenneth Moise, Department of Women's Health, Dell Medical School, Austin, Texas, USA.
• Juan Gonzalez-Velez, Department of Maternal Fetal Medicine, University of California San Francisco, San Francisco, California, USA.
• Kathryn Shanahan, Allo Hope Foundation, Tuscaloosa, Alabama, USA.
• Aaron Shmookler, Department of Pathology and Laboratory Medicine, University of Kentucky School of Medicine, Lexington, Kentucky, USA.
• Meghan Delaney, Department of Pathology and Laboratory Medicine, Children's National Hospital & George Washington University, Washington, DC, USA.

Document Type

Journal Article

Publication Date

2-16-2026

Journal

Transfusion

DOI

10.1111/trf.70124

Keywords

alloimmunization; hemolytic disease of the fetus and newborn

APA Citation

Sherwood, Molly; Weathersby, Bethany; Moise, Kenneth; Gonzalez-Velez, Juan; Shanahan, Kathryn; Shmookler, Aaron; and Delaney, Meghan, "A critical moment: Standardizing red blood cell antibody reporting to reduce hemolytic disease of the fetus and newborn risk" (2026). GW Authored Works. Paper 8709.
https://hsrc.himmelfarb.gwu.edu/gwhpubs/8709

Department

Pathology